NZ183272A - Cyanoalkylureido-cephalosporins - Google Patents

Cyanoalkylureido-cephalosporins

Info

Publication number
NZ183272A
NZ183272A NZ183272A NZ18327277A NZ183272A NZ 183272 A NZ183272 A NZ 183272A NZ 183272 A NZ183272 A NZ 183272A NZ 18327277 A NZ18327277 A NZ 18327277A NZ 183272 A NZ183272 A NZ 183272A
Authority
NZ
New Zealand
Prior art keywords
cyanoalkylureido
cephalosporins
Prior art date
Application number
NZ183272A
Other languages
English (en)
Inventor
Vd Treuner
H Breuer
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NZ183272A publication Critical patent/NZ183272A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ183272A 1976-03-05 1977-02-07 Cyanoalkylureido-cephalosporins NZ183272A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66412876A 1976-03-05 1976-03-05

Publications (1)

Publication Number Publication Date
NZ183272A true NZ183272A (en) 1979-03-28

Family

ID=24664650

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ183272A NZ183272A (en) 1976-03-05 1977-02-07 Cyanoalkylureido-cephalosporins

Country Status (14)

Country Link
US (1) US4096329A (enExample)
JP (1) JPS52108995A (enExample)
AU (1) AU508629B2 (enExample)
BE (1) BE852090A (enExample)
CA (1) CA1109460A (enExample)
DE (1) DE2707490A1 (enExample)
DK (1) DK97177A (enExample)
FR (1) FR2342976A1 (enExample)
GB (1) GB1574791A (enExample)
NL (1) NL7702121A (enExample)
NO (1) NO770757L (enExample)
NZ (1) NZ183272A (enExample)
SE (1) SE7702481L (enExample)
ZA (1) ZA77717B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104389A (ja) * 1982-12-06 1984-06-16 Shionogi & Co Ltd オキサセファム誘導体
JPH0712404U (ja) * 1993-08-09 1995-02-28 有限会社杜の會 生理用フレアーパンツ
CN102675342A (zh) * 2011-03-15 2012-09-19 四平市精细化学品有限公司 7β-氨基-7α-甲氧基-3-[（1-甲基-1H-四唑-5-基）硫甲基]-3-头孢烯-4-羧酸二苯甲酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2309599A1 (de) * 1973-02-26 1974-09-05 Bayer Ag Verfahren zur herstellung von 7-acylamino-desacetoxy-cephalosporansaeurederivaten
US3996217A (en) * 1975-09-08 1976-12-07 E. R. Squibb & Sons, Inc. 3-Triazolylthio derivatives of ureido cephalosporins

Also Published As

Publication number Publication date
BE852090A (fr) 1977-09-05
AU508629B2 (en) 1980-03-27
DK97177A (da) 1977-09-06
SE7702481L (sv) 1977-10-17
FR2342976B1 (enExample) 1980-06-27
US4096329A (en) 1978-06-20
DE2707490A1 (de) 1977-09-08
ZA77717B (en) 1977-12-28
GB1574791A (en) 1980-09-10
NO770757L (no) 1977-09-06
CA1109460A (en) 1981-09-22
NL7702121A (nl) 1977-09-07
JPS52108995A (en) 1977-09-12
FR2342976A1 (fr) 1977-09-30
AU2209077A (en) 1978-08-17

Similar Documents

Publication Publication Date Title
AU517514B2 (en) 3-de-0-methylfortimicins
AU2542577A (en) 4-amino-4-arylcyclohexanones
GB1542539A (en) Bicycle-trailer
CS164777A2 (en) Zpusob ziskavani krystalickeho xylitolu farmaceuricke jakosti
GB1522457A (en) Benzocycloheptafurans
CS474677A2 (en) Obrazovy zesilovac
AU2726877A (en) Benzofuranyl-benzimidazoles
AU3191677A (en) Cyclopentan-1-amine
AU507260B2 (en) N-2-imidazolidinylidene-benzeneamine
AU2451277A (en) Isothiazolopyridines
AU2714177A (en) Phenoxy-hydroxypropylamines
AU1309176A (en) Fire-barriers
GB1538366A (en) Pyridobenzodiazepines
BG23251A1 (en) Stabilograph
AU2893177A (en) Perhydroindolinols
GB1520699A (en) Benzoxazolenes
AU508067B2 (en) Electroradiography
NZ183272A (en) Cyanoalkylureido-cephalosporins
AU2493077A (en) 2-amino-substituted-isothioureido bewzenes
GB1537670A (en) De-tinning
CY1158A (en) Arylmalonamido-1-oxadethiacephalosporins
AU3192177A (en) 2-methoxybenzamides
AU2710877A (en) Benzodioxepins
GB1540313A (en) Low-loader-waggons
AU2664077A (en) Frequency-synthesizer-tuner